News
05 March 2010, The European Medicines Agency
International Workshop on Nanomedicines
The European Medicines Agency will hold a workshop to discuss the state-of-the-science of nanomedicines on
26-27 April 2010 at the Agency’s offices in London.
The aim of this workshop is to bring together regulatory, academic, and industry scientists to share their experiences with the development and use of nanotechnologies in Medicinal Products. The application of nanotechnologies to medicinal science spans over the whole range of medicinal products from disease treatment and prevention to restoration, correction of modification of physiological function or medical diagnoses. Independent views on the main aspects to be considered will be presented at this workshop:
• Experience in evaluating and developing nanomedicines
• Emerging nanotechnology applications in the pharmaceutical area
• Regulatory borderline issues
• Benefit/risk and application of Risk Management principles
• Global outlook on nanomedicines
By fostering the global dimension of the emerging nanomedicines, the Agency expects to further extend the
dialogue opportunities on the requirements and methods considered acceptable for nanomedicines and to support the innovative development.
To express your interest in attending the workshop, please use the attached registration form and send it back to the Agency (martine.vanrooyen@ema.europa.eu) before 15 March 2010.
Please note that approximately 120 places are available for the workshop. Spaces will be allocated on a firstcome-first-serve basis.
Further information can also be obtained from Martine van Rooyen (E-mail: martine.vanrooyen@ema.europa.eu).
The European Medicines Agency looks forward to welcoming you at the workshop.
Last changed: 05 March 2010
